UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

BMC infectious diseases, 2017-08, Vol.17 (1), p.551-551, Article 551

2017

Volltextzugriff (PDF)

A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV

Journal of acquired immune deficiency syndromes (1999), 2023-12, Vol.94 (5), p.474-481

2023

Volltextzugriff (PDF)

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

BMC public health, 2016-08, Vol.16 (1), p.878-878, Article 878

2016

Volltextzugriff (PDF)

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

PloS one, 2015-05, Vol.10 (5), p.e0124741-e0124741

2015

Volltextzugriff (PDF)

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study

PloS one, 2014-04, Vol.9 (4), p.e94768-e94768

2014

Volltextzugriff (PDF)

A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study

AIDS research and therapy, 2020-10, Vol.17 (1), p.61-61, Article 61

2020

Volltextzugriff (PDF)

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Frontiers in immunology, 2019-02, Vol.10, p.233-233

2019

Volltextzugriff (PDF)

Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

BMC infectious diseases, 2018-01, Vol.18 (1), p.10-10, Article 10

2018

Volltextzugriff (PDF)

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

PloS one, 2010-11, Vol.5 (11), p.e13540

2010

Volltextzugriff (PDF)

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment

PloS one, 2016-09, Vol.11 (9), p.e0162320-e0162320

2016

Volltextzugriff (PDF)

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

EBioMedicine, 2021-04, Vol.66, p.103306-103306, Article 103306

2021

Volltextzugriff (PDF)

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

BMC infectious diseases, 2012-02, Vol.12 (1), p.38-38, Article 38

2012

Volltextzugriff (PDF)

Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis

Current HIV research, 2016-01, Vol.14 (4), p.346-353

2016

Volltextzugriff (PDF)

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis

PloS one, 2011-10, Vol.6 (10), p.e26009-e26009

2011

Volltextzugriff (PDF)

Increasing clinical virulence in two decades of the Italian HIV epidemic

PLoS pathogens, 2009-05, Vol.5 (5), p.e1000454-e1000454

2009

Volltextzugriff (PDF)

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

The Lancet (British edition), 2019-01, Vol.393 (10167), p.143-155

2019

Volltextzugriff (PDF)

Hepatitis C Infection Influence on Immune Recovery in HIV-Positive Patients on Successful HAART: The Role of Genotype 3

Current HIV research, 2010-04, Vol.8 (3), p.186-193

2010

Volltextzugriff (PDF)

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

AIDS research and therapy, 2012-06, Vol.9 (1), p.18-18, Article 18

2012

Volltextzugriff (PDF)

Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus

AIDS (London), 2021-10, Vol.35 (12), p.1967-1972

2021

Volltextzugriff (PDF)

Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction

Current HIV research, 2011-04, Vol.9 (3), p.166-173

2011

Volltextzugriff (PDF)

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

Journal of hepatology, 2021-04, Vol.74 (4), p.801-810

2021

Volltextzugriff (PDF)

A novel methodology for large-scale phylogeny partition

Nature communications, 2011-05, Vol.2 (1), p.321-321, Article 321

2011

Volltextzugriff (PDF)

Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3519-3527

2016

Volltextzugriff (PDF)

Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors

International journal of antimicrobial agents, 2019-04, Vol.53 (4), p.515-519

2019

Volltextzugriff (PDF)

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study

BMC infectious diseases, 2017-03, Vol.17 (1), p.193-193, Article 193

2017

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(150)
Berichte
(1)

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study

A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis

Increasing clinical virulence in two decades of the Italian HIV epidemic

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Hepatitis C Infection Influence on Immune Recovery in HIV-Positive Patients on Successful HAART: The Role of Genotype 3

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus

Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

A novel methodology for large-scale phylogeny partition

Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study

Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study

Suchergebnisse filtern